MISSION Therapeutics
MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.
Domain
missiontherapeutics.com
Country
United KingdomIndustry
BiotechnologyEmployees
51-100
Last Funding
$13.3M
Founded
2010
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does MISSION Therapeutics use?+
MISSION Therapeutics uses 16 technologies including WordPress, Adobe Fonts, Complianz.
What industry is MISSION Therapeutics in?+
MISSION Therapeutics operates in the Biotechnology industry.
Where is MISSION Therapeutics based?+
MISSION Therapeutics is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026